APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androgen and Anabolic Steroid

Compare research editions
View pricing & licenses

Selected research

Industry Research

Androgen and Anabolic Steroid Industry Research Report 2026

19 December 2025129 pages

Choose your research edition.

Industry ResearchAndrogen and Anabolic Steroid Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Androgen and Anabolic Steroid Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Androgen and Anabolic Steroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androgen and Anabolic Steroid Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Androgen and Anabolic Steroid Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Androgen and Anabolic Steroid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Androgen and Anabolic Steroid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Androgen and Anabolic Steroid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Androgen and Anabolic Steroid include Acerus Pharmaceuticals, Amneal Pharmaceuticals, Antares Pharma, Auxilium Pharmaceuticals, Bausch Health, Clarus Therapeutics, Endo Pharmaceuticals, Pharmacia and Upjohn and Solvay Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Androgen and Anabolic Steroid market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Androgen and Anabolic Steroid Market by Company

Acerus Pharmaceuticals

Amneal Pharmaceuticals

Antares Pharma

Auxilium Pharmaceuticals

Bausch Health

Clarus Therapeutics

Endo Pharmaceuticals

Pharmacia and Upjohn

Solvay Pharmaceuticals

Upsher-Smith

AbbVie

GlaxoSmithKline

Pfizer

Teva

Androgen and Anabolic Steroid Segment by Type

Methyltestosterone

Testosterone

Fluoxymesterone

Others

Androgen and Anabolic Steroid Segment by Application

Hospitals

Pharmacy

Others

Androgen and Anabolic Steroid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgen and Anabolic Steroid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgen and Anabolic Steroid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgen and Anabolic Steroid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Androgen and Anabolic Steroid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Androgen and Anabolic Steroid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Androgen and Anabolic Steroid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Androgen and Anabolic Steroid Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Androgen and Anabolic Steroid Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Androgen and Anabolic Steroid Sales Market Share by Manufacturers (2021-2026) Table 8. Global Androgen and Anabolic Steroid Revenue of Manufacturers (2021-2026) Table 9. Global Androgen and Anabolic Steroid Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Androgen and Anabolic Steroid Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Androgen and Anabolic Steroid Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Androgen and Anabolic Steroid, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Androgen and Anabolic Steroid, Product Type & Application Table 14. Global Androgen and Anabolic Steroid Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Androgen and Anabolic Steroid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Acerus Pharmaceuticals Company Information Table 19. Acerus Pharmaceuticals Business Overview Table 20. Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 22. Acerus Pharmaceuticals Recent Developments Table 23. Amneal Pharmaceuticals Company Information Table 24. Amneal Pharmaceuticals Business Overview Table 25. Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 27. Amneal Pharmaceuticals Recent Developments Table 28. Antares Pharma Company Information Table 29. Antares Pharma Business Overview Table 30. Antares Pharma Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Antares Pharma Androgen and Anabolic Steroid Product Portfolio Table 32. Antares Pharma Recent Developments Table 33. Auxilium Pharmaceuticals Company Information Table 34. Auxilium Pharmaceuticals Business Overview Table 35. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 37. Auxilium Pharmaceuticals Recent Developments Table 38. Bausch Health Company Information Table 39. Bausch Health Business Overview Table 40. Bausch Health Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Bausch Health Androgen and Anabolic Steroid Product Portfolio Table 42. Bausch Health Recent Developments Table 43. Clarus Therapeutics Company Information Table 44. Clarus Therapeutics Business Overview Table 45. Clarus Therapeutics Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Clarus Therapeutics Androgen and Anabolic Steroid Product Portfolio Table 47. Clarus Therapeutics Recent Developments Table 48. Endo Pharmaceuticals Company Information Table 49. Endo Pharmaceuticals Business Overview Table 50. Endo Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Endo Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 52. Endo Pharmaceuticals Recent Developments Table 53. Pharmacia and Upjohn Company Information Table 54. Pharmacia and Upjohn Business Overview Table 55. Pharmacia and Upjohn Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Pharmacia and Upjohn Androgen and Anabolic Steroid Product Portfolio Table 57. Pharmacia and Upjohn Recent Developments Table 58. Solvay Pharmaceuticals Company Information Table 59. Solvay Pharmaceuticals Business Overview Table 60. Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 62. Solvay Pharmaceuticals Recent Developments Table 63. Upsher-Smith Company Information Table 64. Upsher-Smith Business Overview Table 65. Upsher-Smith Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Upsher-Smith Androgen and Anabolic Steroid Product Portfolio Table 67. Upsher-Smith Recent Developments Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AbbVie Androgen and Anabolic Steroid Product Portfolio Table 72. AbbVie Recent Developments Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Androgen and Anabolic Steroid Product Portfolio Table 77. GlaxoSmithKline Recent Developments Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Androgen and Anabolic Steroid Product Portfolio Table 82. Pfizer Recent Developments Table 83. Teva Company Information Table 84. Teva Business Overview Table 85. Teva Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Teva Androgen and Anabolic Steroid Product Portfolio Table 87. Teva Recent Developments Table 88. Global Androgen and Anabolic Steroid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Androgen and Anabolic Steroid Sales by Region (2021-2026) & (K Units) Table 90. Global Androgen and Anabolic Steroid Sales Market Share by Region (2021-2026) Table 91. Global Androgen and Anabolic Steroid Sales by Region (2027-2032) & (K Units) Table 92. Global Androgen and Anabolic Steroid Sales Market Share by Region (2027-2032) Table 93. Global Androgen and Anabolic Steroid Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2021-2026) Table 95. Global Androgen and Anabolic Steroid Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2027-2032) Table 97. North America Androgen and Anabolic Steroid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 99. North America Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 100. North America Androgen and Anabolic Steroid Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Androgen and Anabolic Steroid Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Androgen and Anabolic Steroid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 104. Europe Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 105. Europe Androgen and Anabolic Steroid Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Androgen and Anabolic Steroid Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Androgen and Anabolic Steroid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Androgen and Anabolic Steroid Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Androgen and Anabolic Steroid Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Androgen and Anabolic Steroid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 114. South America Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 115. South America Androgen and Anabolic Steroid Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Androgen and Anabolic Steroid Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Androgen and Anabolic Steroid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Androgen and Anabolic Steroid Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Androgen and Anabolic Steroid Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Androgen and Anabolic Steroid Sales by Type (2021-2026) & (K Units) Table 123. Global Androgen and Anabolic Steroid Sales by Type (2027-2032) & (K Units) Table 124. Global Androgen and Anabolic Steroid Sales Market Share by Type (2021-2026) Table 125. Global Androgen and Anabolic Steroid Sales Market Share by Type (2027-2032) Table 126. Global Androgen and Anabolic Steroid Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Androgen and Anabolic Steroid Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2021-2026) Table 129. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2027-2032) Table 130. Global Androgen and Anabolic Steroid Price by Type (2021-2026) & (US$/Unit) Table 131. Global Androgen and Anabolic Steroid Price by Type (2027-2032) & (US$/Unit) Table 132. Global Androgen and Anabolic Steroid Sales by Application (2021-2026) & (K Units) Table 133. Global Androgen and Anabolic Steroid Sales by Application (2027-2032) & (K Units) Table 134. Global Androgen and Anabolic Steroid Sales Market Share by Application (2021-2026) Table 135. Global Androgen and Anabolic Steroid Sales Market Share by Application (2027-2032) Table 136. Global Androgen and Anabolic Steroid Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Androgen and Anabolic Steroid Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2021-2026) Table 139. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2027-2032) Table 140. Global Androgen and Anabolic Steroid Price by Application (2021-2026) & (US$/Unit) Table 141. Global Androgen and Anabolic Steroid Price by Application (2027-2032) & (US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Androgen and Anabolic Steroid Distributors List Table 145. Androgen and Anabolic Steroid Customers List Table 146. Androgen and Anabolic Steroid Industry Trends Table 147. Androgen and Anabolic Steroid Industry Drivers Table 148. Androgen and Anabolic Steroid Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Androgen and Anabolic Steroid Product Image Figure 5. Global Androgen and Anabolic Steroid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Androgen and Anabolic Steroid Market Size (2021-2032) & (US$ Million) Figure 7. Global Androgen and Anabolic Steroid Sales (2021-2032) & (K Units) Figure 8. Global Androgen and Anabolic Steroid Average Price (US$/Unit) & (2021-2032) Figure 9. Methyltestosterone Product Image Figure 10. Testosterone Product Image Figure 11. Fluoxymesterone Product Image Figure 12. Others Product Image Figure 13. Hospitals Product Image Figure 14. Pharmacy Product Image Figure 15. Others Product Image Figure 16. Global Androgen and Anabolic Steroid Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Androgen and Anabolic Steroid, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Androgen and Anabolic Steroid Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Androgen and Anabolic Steroid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Androgen and Anabolic Steroid Sales by Region in 2025 Figure 22. Global Androgen and Anabolic Steroid Revenue by Region in 2025 Figure 23. North America Androgen and Anabolic Steroid Market Size by Country in 2025 Figure 24. North America Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 25. North America Androgen and Anabolic Steroid Revenue Market Share by Country (2021-2032) Figure 26. United States Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Androgen and Anabolic Steroid Market Size by Country in 2025 Figure 29. Europe Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 30. Europe Androgen and Anabolic Steroid Revenue Market Share by Country (2021-2032) Figure 31. Germany Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Androgen and Anabolic Steroid Market Size by Country in 2025 Figure 37. Asia Pacific Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Androgen and Anabolic Steroid Revenue Market Share by Country (2021-2032) Figure 39. China Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Androgen and Anabolic Steroid Market Size by Country in 2025 Figure 48. South America Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 49. South America Androgen and Anabolic Steroid Revenue Market Share by Country (2021-2032) Figure 50. Mexico Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Androgen and Anabolic Steroid Market Size by Country in 2025 Figure 54. Middle East and Africa Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Androgen and Anabolic Steroid Revenue Market Share by Country (2021-2032) Figure 56. Turkey Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Androgen and Anabolic Steroid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Androgen and Anabolic Steroid Sales Market Share by Type (2021-2032) Figure 60. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2021-2032) Figure 61. Global Androgen and Anabolic Steroid Price (US$/Unit) by Type (2021-2032) Figure 62. Global Androgen and Anabolic Steroid Sales Market Share by Application (2021-2032) Figure 63. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2021-2032) Figure 64. Global Androgen and Anabolic Steroid Price (US$/Unit) by Application (2021-2032) Figure 65. Androgen and Anabolic Steroid Value Chain Figure 66. Androgen and Anabolic Steroid Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Androgen and Anabolic Steroid Industry Opportunities and Challenges

Scope & coverage.

Types
  • Methyltestosterone
  • Testosterone
  • Fluoxymesterone
  • Others
Applications
  • Hospitals
  • Pharmacy
  • Others
Companies covered
  • Acerus Pharmaceuticals
  • Amneal Pharmaceuticals
  • Antares Pharma
  • Auxilium Pharmaceuticals
  • Bausch Health
  • Clarus Therapeutics
  • Endo Pharmaceuticals
  • Pharmacia and Upjohn
  • Solvay Pharmaceuticals
  • Upsher-Smith
  • AbbVie
  • GlaxoSmithKline
  • Pfizer
  • Teva

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Androgen and Anabolic Steroid Market Size (2021-2032)
  4. 2.2.2 Global Androgen and Anabolic Steroid Sales (2021-2032)
  5. 2.2.3 Global Androgen and Anabolic Steroid Market Average Price (2021-2032)
  6. 2.3 Androgen and Anabolic Steroid by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Methyltestosterone
  9. 2.3.3 Testosterone
  10. 2.3.4 Fluoxymesterone
  11. 2.3.5 Others
  12. 2.4 Androgen and Anabolic Steroid by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospitals
  15. 2.4.3 Pharmacy
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Androgen and Anabolic Steroid Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Androgen and Anabolic Steroid Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Androgen and Anabolic Steroid Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Androgen and Anabolic Steroid Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Androgen and Anabolic Steroid Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Androgen and Anabolic Steroid, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Androgen and Anabolic Steroid, Product Type & Application
  8. 3.8 Global Manufacturers of Androgen and Anabolic Steroid, Established Date
  9. 3.9 Global Androgen and Anabolic Steroid Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Acerus Pharmaceuticals
  2. 4.1.1 Acerus Pharmaceuticals Company Information
  3. 4.1.2 Acerus Pharmaceuticals Business Overview
  4. 4.1.3 Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  6. 4.1.5 Acerus Pharmaceuticals Recent Developments
  7. 4.2 Amneal Pharmaceuticals
  8. 4.2.1 Amneal Pharmaceuticals Company Information
  9. 4.2.2 Amneal Pharmaceuticals Business Overview
  10. 4.2.3 Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  12. 4.2.5 Amneal Pharmaceuticals Recent Developments
  13. 4.3 Antares Pharma
  14. 4.3.1 Antares Pharma Company Information
  15. 4.3.2 Antares Pharma Business Overview
  16. 4.3.3 Antares Pharma Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Antares Pharma Androgen and Anabolic Steroid Product Portfolio
  18. 4.3.5 Antares Pharma Recent Developments
  19. 4.4 Auxilium Pharmaceuticals
  20. 4.4.1 Auxilium Pharmaceuticals Company Information
  21. 4.4.2 Auxilium Pharmaceuticals Business Overview
  22. 4.4.3 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  24. 4.4.5 Auxilium Pharmaceuticals Recent Developments
  25. 4.5 Bausch Health
  26. 4.5.1 Bausch Health Company Information
  27. 4.5.2 Bausch Health Business Overview
  28. 4.5.3 Bausch Health Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Bausch Health Androgen and Anabolic Steroid Product Portfolio
  30. 4.5.5 Bausch Health Recent Developments
  31. 4.6 Clarus Therapeutics
  32. 4.6.1 Clarus Therapeutics Company Information
  33. 4.6.2 Clarus Therapeutics Business Overview
  34. 4.6.3 Clarus Therapeutics Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Clarus Therapeutics Androgen and Anabolic Steroid Product Portfolio
  36. 4.6.5 Clarus Therapeutics Recent Developments
  37. 4.7 Endo Pharmaceuticals
  38. 4.7.1 Endo Pharmaceuticals Company Information
  39. 4.7.2 Endo Pharmaceuticals Business Overview
  40. 4.7.3 Endo Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Endo Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  42. 4.7.5 Endo Pharmaceuticals Recent Developments
  43. 4.8 Pharmacia and Upjohn
  44. 4.8.1 Pharmacia and Upjohn Company Information
  45. 4.8.2 Pharmacia and Upjohn Business Overview
  46. 4.8.3 Pharmacia and Upjohn Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pharmacia and Upjohn Androgen and Anabolic Steroid Product Portfolio
  48. 4.8.5 Pharmacia and Upjohn Recent Developments
  49. 4.9 Solvay Pharmaceuticals
  50. 4.9.1 Solvay Pharmaceuticals Company Information
  51. 4.9.2 Solvay Pharmaceuticals Business Overview
  52. 4.9.3 Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  54. 4.9.5 Solvay Pharmaceuticals Recent Developments
  55. 4.10 Upsher-Smith
  56. 4.10.1 Upsher-Smith Company Information
  57. 4.10.2 Upsher-Smith Business Overview
  58. 4.10.3 Upsher-Smith Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Upsher-Smith Androgen and Anabolic Steroid Product Portfolio
  60. 4.10.5 Upsher-Smith Recent Developments
  61. 4.11 AbbVie
  62. 4.11.1 AbbVie Company Information
  63. 4.11.2 AbbVie Business Overview
  64. 4.11.3 AbbVie Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 AbbVie Androgen and Anabolic Steroid Product Portfolio
  66. 4.11.5 AbbVie Recent Developments
  67. 4.12 GlaxoSmithKline
  68. 4.12.1 GlaxoSmithKline Company Information
  69. 4.12.2 GlaxoSmithKline Business Overview
  70. 4.12.3 GlaxoSmithKline Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 GlaxoSmithKline Androgen and Anabolic Steroid Product Portfolio
  72. 4.12.5 GlaxoSmithKline Recent Developments
  73. 4.13 Pfizer
  74. 4.13.1 Pfizer Company Information
  75. 4.13.2 Pfizer Business Overview
  76. 4.13.3 Pfizer Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Pfizer Androgen and Anabolic Steroid Product Portfolio
  78. 4.13.5 Pfizer Recent Developments
  79. 4.14 Teva
  80. 4.14.1 Teva Company Information
  81. 4.14.2 Teva Business Overview
  82. 4.14.3 Teva Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Teva Androgen and Anabolic Steroid Product Portfolio
  84. 4.14.5 Teva Recent Developments
5 Global Androgen and Anabolic Steroid Market Scenario by Region
  1. 5.1 Global Androgen and Anabolic Steroid Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Androgen and Anabolic Steroid Sales by Region: 2021-2032
  3. 5.2.1 Global Androgen and Anabolic Steroid Sales by Region: 2021-2026
  4. 5.2.2 Global Androgen and Anabolic Steroid Sales by Region: 2027-2032
  5. 5.3 Global Androgen and Anabolic Steroid Revenue by Region: 2021-2032
  6. 5.3.1 Global Androgen and Anabolic Steroid Revenue by Region: 2021-2026
  7. 5.3.2 Global Androgen and Anabolic Steroid Revenue by Region: 2027-2032
  8. 5.4 North America Androgen and Anabolic Steroid Market Facts & Figures by Country
  9. 5.4.1 North America Androgen and Anabolic Steroid Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Androgen and Anabolic Steroid Sales by Country (2021-2032)
  11. 5.4.3 North America Androgen and Anabolic Steroid Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Androgen and Anabolic Steroid Market Facts & Figures by Country
  15. 5.5.1 Europe Androgen and Anabolic Steroid Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Androgen and Anabolic Steroid Sales by Country (2021-2032)
  17. 5.5.3 Europe Androgen and Anabolic Steroid Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Androgen and Anabolic Steroid Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Androgen and Anabolic Steroid Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Androgen and Anabolic Steroid Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Androgen and Anabolic Steroid Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Androgen and Anabolic Steroid Market Facts & Figures by Country
  35. 5.7.1 South America Androgen and Anabolic Steroid Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Androgen and Anabolic Steroid Sales by Country (2021-2032)
  37. 5.7.3 South America Androgen and Anabolic Steroid Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Androgen and Anabolic Steroid Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Androgen and Anabolic Steroid Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Androgen and Anabolic Steroid Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Androgen and Anabolic Steroid Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Androgen and Anabolic Steroid Sales by Type (2021-2032)
  2. 6.1.1 Global Androgen and Anabolic Steroid Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Androgen and Anabolic Steroid Sales Market Share by Type (2021-2032)
  4. 6.2 Global Androgen and Anabolic Steroid Revenue by Type (2021-2032)
  5. 6.2.1 Global Androgen and Anabolic Steroid Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Androgen and Anabolic Steroid Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Androgen and Anabolic Steroid Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Androgen and Anabolic Steroid Sales by Application (2021-2032)
  2. 7.1.1 Global Androgen and Anabolic Steroid Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Androgen and Anabolic Steroid Sales Market Share by Application (2021-2032)
  4. 7.2 Global Androgen and Anabolic Steroid Revenue by Application (2021-2032)
  5. 7.2.1 Global Androgen and Anabolic Steroid Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Androgen and Anabolic Steroid Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Androgen and Anabolic Steroid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Androgen and Anabolic Steroid Value Chain Analysis
  2. 8.1.1 Androgen and Anabolic Steroid Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Androgen and Anabolic Steroid Production Mode & Process
  5. 8.2 Androgen and Anabolic Steroid Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Androgen and Anabolic Steroid Distributors
  8. 8.2.3 Androgen and Anabolic Steroid Customers
9 Global Androgen and Anabolic Steroid Analyzing Market Dynamics
  1. 9.1 Androgen and Anabolic Steroid Industry Trends
  2. 9.2 Androgen and Anabolic Steroid Industry Drivers
  3. 9.3 Androgen and Anabolic Steroid Industry Opportunities and Challenges
  4. 9.4 Androgen and Anabolic Steroid Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst